Contrexyn

Quick links to important sections

Contrexyn

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Contrexyn

Property Description
Active Ingredients Acetylsalicylic Acid (ASA) and Glycine
Forms Oral Tablets, Chewable Tablets, Syrup, Drops
Pharmacological Class Non-Steroidal Anti-Inflammatory Drug (NSAID) and Analgesic combination
General Purpose Relief from general pain and fever
Origin Synthetic (ASA) and Naturally Occurring Amino Acid (Glycine)

Contrexyn is a fixed-dose pharmaceutical preparation recognized as a combination product that contains the active ingredients Acetylsalicylic Acid (ASA) and Glycine. It is primarily classified within the Non-Steroidal Anti-Inflammatory Drug (NSAID) class, which provides core therapeutic actions related to inflammation and discomfort, a property clinically recognized for its broad application in pain management.


What Type of Medicine is Contrexyn, and What Does it Contain?

Contrexyn is an NSAID/Analgesic combination defined by the inclusion of two agents: the pain and fever mediator Acetylsalicylic Acid and the amino acid Glycine. The ASA component is a synthetic compound recognized for its established antipyretic (fever-reducing) and analgesic (pain-relieving) effects. ASA is a well-studied Salicylate, and its classification is consistent across global regulatory bodies.

The second component, Glycine, is a naturally occurring amino acid included primarily to modify the drug's properties. This structure differentiates Contrexyn from standard ASA formulations by incorporating Glycine, which is intended to help improve the gastrointestinal tolerability of the ASA component during use. This dual composition is specifically structured to promote better acceptance by the digestive system.


General Therapeutic Purpose and Available Forms

The overall therapeutic objective of Contrexyn is to provide general relief from the common, self-limiting symptoms of pain and fever, such as managing elevated temperature associated with a cold. Contrexyn is designed for the oral route of administration and is distinguished by its availability in several high-level dosage forms, including Tablets for general use, and specialized preparations like Syrups and Drops for younger demographics. This variation in forms is a key feature, ensuring the medicine can be conveniently used by varying age groups for the temporary relief of these core symptoms.

Regulatory References

  1. National Library of Medicine, Acetylsalicylic Acid and Glycine

What side effects are possible with Contrexyn?

Possible Side Effects and Safety Information for Contrexyn

Contrexyn, as a non-aspirin Nonsteroidal Anti-inflammatory Drug (NSAID), carries mandatory safety warnings regarding serious, life-threatening adverse reactions affecting the cardiovascular and gastrointestinal systems, as documented by governmental regulatory authorities like the FDA.


Key Adverse Reaction Scope

System/Adverse Event Category Risk Summary (Regulatory Basis)
Cardiovascular Thrombotic Events Increased risk of serious events, including myocardial infarction (heart attack) and stroke, which can be fatal. This risk may occur early in treatment and may increase with longer duration of use and higher doses.
Gastrointestinal Events Increased risk of serious adverse reactions, including bleeding, ulceration, and perforation of the stomach or intestines, which can also be fatal. This risk is higher with longer treatment duration and in patients with a prior history of GI disease.
Other Serious Risks New-onset or worsening of hypertension (high blood pressure), heart failure, liver toxicity (severe hepatic reactions), deterioration of renal function, and serious skin reactions (e.g., Stevens-Johnson Syndrome).

Population-Specific Safety Considerations

  • Cardiovascular Disease: Patients with pre-existing heart disease or risk factors have a higher baseline risk, making the NSAID-related risk increase more consequential.
  • Coronary Artery Bypass Graft (CABG) Surgery: Contrexyn is contraindicated for the treatment of peri-operative pain immediately following CABG surgery.
  • Pregnancy: The use of NSAIDs should be avoided from 20 weeks of gestation onward due to the risk of fetal renal dysfunction leading to low amniotic fluid (oligohydramnios).
  • Elderly Patients: Older patients are at a greater risk for serious gastrointestinal adverse events.

Connection to the Overall Safety Profile

The regulatory safety profile for Contrexyn is structured around mandatory Boxed Warnings that define the core risks associated with the non-aspirin NSAID class. This official safety information establishes that the primary concerns are the potential for serious thrombotic events and severe gastrointestinal damage, with the risk level explicitly tied to the dose, duration of exposure, and the presence of specific co-morbidities or conditions. The safety structure emphasizes the need for caution, particularly in vulnerable populations and when long-term use is considered.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information for Contrexyn (Acetylsalicylic Acid/Salicylates) overdose is strictly defined by documented clinical manifestations and mandated emergency response actions. Toxicity may present with gastrointestinal distress, tinnitus (ringing in the ears), dizziness, and signs of metabolic disturbance such as hyperventilation (rapid or deep breathing) and sweating. Severe or life-threatening outcomes documented in regulatory labeling include seizures, coma, acute kidney failure, cerebral edema, and pulmonary edema.

Required Emergency Actions

Immediate medical attention must be sought following a suspected toxic ingestion or the onset of severe symptoms. Official guidance requires contacting emergency medical services or a poison control center immediately. The regulatory profile states that no specific antidote is known for salicylate poisoning.

Management and Monitoring

Overdose management is symptomatic and supportive. This includes mandated procedures like the administration of activated charcoal and measures to enhance elimination, such as urinary alkalization or hemodialysis for severe cases. Regulatory documents require close hospital monitoring, including serial measurement of serum salicylate levels and correction of acid-base imbalances. Population-specific risks include the documented potential for Reye's syndrome in children and teenagers with concomitant viral illness.

Therapeutic Uses of Contrexyn

What Contrexyn Treats: Main Uses and Benefits

Contrexyn is commonly used to help manage symptoms related to physical discomfort and systemic imbalance. The medication is applied across domains where additional symptomatic support is needed, primarily by addressing fever and mild to moderate pain.

The medication is relevant for managing certain symptoms of increased neurological or muscular activity, such as headaches, muscle aches, and other symptoms related to physical discomfort. The medication is applied across domains where short-term symptom management is appropriate. This supportive action contributes to easing the overall symptom load during symptomatic periods.

The medication is relevant in conditions characterized by periods of heightened symptoms, such as those associated with the common cold or flu. It helps address symptom clusters that may appear suddenly, such as a high temperature combined with general malaise.

“Contrexyn provides supportive relief when symptoms interfere with routine activities, helping patients cope more steadily with symptom fluctuations.”

By easing these manifestations, Contrexyn supports patients during episodes of heightened discomfort and assists with maintaining comfort when symptoms interfere with routine activities and general well-being.

Quick Fact: Relief for Fever and Pain

Eligibility and Restrictions for Use

Official Population Eligibility for Contrexyn

Contrexyn, an NSAID combination containing Acetylsalicylic Acid (ASA), is subject to strict eligibility rules documented by regulatory authorities.


Absolute Contraindications (Must Not Use)

Use is prohibited for patients with a history of allergy to ASA or other NSAIDs, active peptic ulcer disease or history of gastrointestinal bleeding, and haemorrhagic disorders (bleeding disorders). It is also contraindicated in those with severe hepatic (liver), severe renal (kidney), or severe cardiac failure.


Age and Pregnancy Restrictions

  • Pediatric Use: The medicine is not recommended for children and adolescents under 16 years of age due to the serious, life-threatening risk of Reye's syndrome, especially when the child has a viral illness like flu or chickenpox.
  • Pregnancy: Contrexyn is contraindicated during the third trimester of pregnancy due to the risk of harm to the fetus. Use during the first and second trimesters is restricted to cases where the benefit is deemed necessary.
  • Older Adults: Patients mathbfge 60 years should use the medicine with caution due to increased susceptibility to adverse effects, especially GI bleeding.

Conditional Use Requirements

Caution is required for patients with moderate hepatic or renal impairment, uncontrolled hypertension, or a history of asthma or nasal polyps.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Contrexyn is a combination product that commonly contains active ingredients such as Acetylsalicylic Acid (Aspirin), Paracetamol (Acetaminophen), and Caffeine. The potential for drug interactions is determined by the properties of these components. Patients should be aware that combining this medicine with certain other products may increase the risk of adverse effects or alter the effectiveness of either medicine.

Clinically Significant Interactions

  • Other NSAIDs and Salicylates: Concurrent use of other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) or products containing Aspirin is generally not recommended due to a significantly increased risk of gastrointestinal bleeding and ulceration.
  • Anticoagulant Medicines (Blood Thinners): The Aspirin component interferes with platelet function. Combining this medicine with anticoagulants (such as warfarin) or other drugs that affect blood clotting may heighten the risk of severe bleeding.
  • Other Paracetamol/Acetaminophen Products: Taking any other medicine, whether prescription or over-the-counter, that contains Paracetamol/Acetaminophen significantly increases the risk of severe liver toxicity.
  • Alcohol: Consumption of alcohol increases the risk of both gastrointestinal bleeding (due to Aspirin) and liver damage (due to Paracetamol).
  • Antihypertensive and Diuretic Medicines: The Aspirin component may diminish the blood pressure-lowering effect of certain medicines, including ACE inhibitors, Angiotensin Receptor Blockers (ARBs), and Diuretics. Concomitant use with these classes may also increase the risk of kidney function deterioration, particularly in elderly or volume-depleted patients.

Mechanism of Action

Contrexyn is a small molecule antagonist of the RANKL receptor, which is expressed on the surface of pre-osteoclasts and mature osteoclasts. RANKL binding to its receptor initiates the intracellular signaling cascade that drives osteoclast differentiation, maturation, and survival.

By inhibiting this molecular pathway, Contrexyn reduces the formation and activity of osteoclasts. The resultant decrease in the rate of bone resorption leads to a corresponding shift in the physiological bone remodeling balance toward net bone formation. This specific interaction with the RANKL receptor modulates the osteoclastogenesis cascade. The mechanism focuses exclusively on the cellular and molecular dynamics governing bone cell regulation, without addressing clinical effects or patient outcomes.

Dosage and Administration Information

How to Use Contrexyn: Official Administration Guidelines

Contrexyn is a fixed-dose combination product containing Acetylsalicylic Acid (ASA) and Glycine that is administered strictly by the oral route. The medicine is used on an as-needed (p.r.n.) schedule for temporary symptomatic relief and is not intended for continuous, long-term daily use. This usage protocol is standardized across official prescribing information to ensure proper administration of the ASA component.


Official Dosing and Frequency

Instruction Domain Official Labeled Instruction
Standard Single Dose 325 mg to 650 mg of Acetylsalicylic Acid (ASA)
Dosing Frequency Repeat dose every 4 to 6 hours as required
Maximum Daily Limit Do not exceed 4000 mg ASA in any 24-hour period

Administration and Duration Constraints

Intake Conditions: Proper administration requires taking the dose with a full glass of water. Official guidance often advises taking the medicine with food to enhance the gastrointestinal tolerance provided by the Glycine component. Non-chewable solid forms must be swallowed whole and must not be crushed, split, or dissolved.

Age-Specific Use: Use in children and adolescents under 16 years of age is generally not recommended unless specific medical advice is sought, requiring lower-strength liquid forms or chewable tablets administered according to age- or weight-specific guidelines.

Course Duration: Use is designated as short-term, limited to the duration of acute symptoms. Official protocols mandate that use must be discontinued if symptoms persist beyond a specified duration, such as 3 days for fever or 10 days for pain. This constraint defines the maximum length of time the medicine is administered without re-evaluation.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Contrexyn


Evidence for Symptomatic Relief of Pain and Fever

Research exploring the general use of the primary component in Contrexyn is extensive, largely relying on meta-analyses that synthesize findings from numerous well-designed Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time by measuring outcomes related to physical discomfort and systemic imbalance in adults with episodic symptom patterns. Analyses describe patterns where research reported how symptoms evolved in the observed populations, but also that patient-reported digestive discomfort was examined in comparison to an inactive substance. What remains uncertain is how these findings apply directly to the specific combination product, as the bulk of this evidence focuses on the core active component alone.


Research on Gastrointestinal Tolerability

Research specifically examined the role of the Glycine component in Contrexyn through large-scale noninterventional trials (observational studies). These studies monitored outcomes related to patient-reported perceived discomfort and overall tolerability rating scores for the specific formulation, often over periods of several weeks. Findings describe patterns where patients transitioning to the ASA+Glycine formulation reported outcomes related to their perceived discomfort in comparison to their previous non-combination regimens. The key evidence examining tolerability comes from a noninterventional study design, and limited comparative evidence exists from direct, randomized trials against a standard formulation.


Duration of Evidence and Research Gaps

Research exploring short-term symptom changes, such as those related to pain and fever, is typically based on very short-term follow-up durations (often a single dose). Conversely, the noninterventional research on tolerability was observed in studies with longer follow-up durations, with participants monitored for several weeks. Long-term effects are not fully established for either use. Data for certain subgroups, such as older adults or those with specific health conditions, remain insufficient. A lack of direct, head-to-head comparative trials against plain ASA for short-term use also persists in the evidence landscape.

Key Studies & References

  1. Study exploring the specific combination of Acetylsalicylic Acid and Glycine

Frequently Asked Questions (FAQ)

Common questions about Contrexyn (FAQ)

Q: How long does it typically take for a person to notice the expected effects of Contrexyn?

While the official product information does not state a precise time for the onset of action, the regulatory dosing schedule for the active ingredient allows for re-dosing every 4 to 6 hours as needed for temporary relief. This interval is used to establish the general expected duration before a subsequent dose may be taken.


Q: Is Contrexyn considered a high-alert medication?

Contrexyn is not typically included on standard, universally published lists of high-alert medications, which are used to flag medicines with a heightened risk of causing significant harm if used in error. However, regulatory documents include mandatory serious warnings regarding potential complications like bleeding and thrombotic events that require careful consideration during use.


Q: What happens if I miss a scheduled time to take Contrexyn?

The medicine is designated for as-needed (p.r.n.) use, not a continuous daily schedule. Regulatory consensus generally indicates that a patient should avoid taking a double dose to compensate. Official guidance indicates use may be resumed by taking a single dose when symptomatic relief is needed.


Q: Does Contrexyn have a risk of dependence or addiction?

The product's main active component, Acetylsalicylic Acid (ASA), is not classified as a controlled substance by regulatory bodies like the DEA. This classification indicates that the medicine is not considered to have a high potential for abuse or dependence.


Q: Can Contrexyn affect my ability to drive or operate heavy machinery?

Regulatory safety documents for the active components do not typically list side effects that would impair the ability to drive or safely operate machinery, such as significant drowsiness or dizziness. As with any medicine, it is important to observe how the product affects personal attention or motor skills.


Q: Is there a generic version of Contrexyn available?

Products containing the same two active ingredients, Acetylsalicylic Acid (ASA) and Glycine, are available under various generic and brand names globally, based on their specific composition and formulation.


Q: What should be done if Contrexyn is taken by someone who is not eligible to use it?

Official regulatory labels emphasize that if the product is taken by an individual who is not eligible (such as a child with a viral illness) or in an accidental overdose, it is advised to immediately contact a Poison Control Center or seek emergency medical attention.


Q: Can taking Contrexyn affect the results of common lab tests?

Official regulatory labels indicate that the active ingredient, Acetylsalicylic Acid (ASA), is known to interfere with the results of certain laboratory tests. It is important that any healthcare provider or laboratory conducting tests is aware of the medicine being used.


Q: Are there any religious or dietary restrictions related to Contrexyn?

Regulatory classification shows that the Glycine component is a naturally occurring amino acid. However, the final product label does not typically list specific religious or specialized dietary certifications for the finished medicine. This information is detailed in the product’s official prescribing information.


Q: What are the non-drug components (excipients) in Contrexyn?

Official regulatory labels and package inserts are required to list all non-medicinal components (excipients), which are the inactive substances that make up the final dosage form.


Q: Does Contrexyn have known interactions with vaccines?

Regulatory guidance for immunization does not typically list the specific combination of Acetylsalicylic Acid and Glycine as a general contraindication or precaution for most immunizations.


Q: Does Contrexyn affect mood or emotional state?

Regulatory labels for the active components of this medicine do not typically list changes in mood or emotional state, such as anxiety or depression, as common or significant adverse reactions.


Q: Are there any warnings about taking Contrexyn while breastfeeding?

Official regulatory labeling is required to contain specific information on the transfer of the drug into human milk and the resulting level of risk to a nursing infant. This information is detailed in the product's official prescribing documents.


Q: Are there any specific foods or drinks to avoid while taking Contrexyn?

The official label explicitly warns that alcohol consumption increases the risk of serious side effects, including gastrointestinal bleeding. While no specific foods are forbidden, official guidance advises taking the medicine with food to help minimize digestive upset.


Q: Is it possible for Contrexyn to interact with over-the-counter cold medicines?

Official labels contain explicit warnings against combining Contrexyn with other products that contain Paracetamol (Acetaminophen) or other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). These ingredients are very common in many over-the-counter cold and flu remedies.


Q: Are there any known interactions between Contrexyn and common supplements like vitamins D or C?

Official regulatory documents caution that certain vitamin and mineral supplements may interact with the active component, Acetylsalicylic Acid. Official documents emphasize the importance of informing a healthcare provider about all supplements being used.

How should Contrexyn be stored and disposed of?

How to Store and Dispose of Contrexyn?

Storage Requirements

Contrexyn must be stored at room temperature (e.g., below 25°C or 77°F), away from excess moisture and heat, and protected from direct light. Keep the medication in its original container and ensure the lid is tightly closed to prevent degradation of the active ingredients. It is mandatory to store Contrexyn out of the sight and reach of children.

Handling and Disposal

Do not freeze the medication. Discard any product that has passed its expiration date or exhibits signs of degradation, such as a strong vinegar odor. The preferred method for disposal is using a drug take-back program. If a program is unavailable, mix the unused medicine with an undesirable substance (e.g., used coffee grounds), place it in a sealed container, and discard it with household trash; do not flush it down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Contrexyn found in:

A-Z Index: